β2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice

Cardiovascular Research

Volumn 85, Issue 4, 2010, Pages 853-863

  Merched, Aksam ^a,b   Tollefson, Katherine ^a   Chan, Lawrence ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b INSERM   (France)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Adhesion; Atherosclerosis; Inflammation; Integrins; Mice

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; BETA2 INTEGRIN; CD18 ANTIGEN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BLOOD VESSEL WALL; BONE MARROW TRANSPLANTATION; CELL ISOLATION; CONTROLLED STUDY; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; GENE EXPRESSION PROFILING; KNOCKOUT MOUSE; LEUKOCYTE; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULITIS;

ANIMALS; ANTIGENS, CD18; APOPTOSIS; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; DISEASE PROGRESSION; DYSLIPIDEMIAS; FEMALE; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHAGOCYTOSIS; RECEPTORS, LDL; VASCULITIS;

EID: 76749109830     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp347     Document Type: Article

References (30)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
2. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874.
3. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signalling. Annu Rev Immunol 2007;25:619-647.
4. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006;6:173-182.
5. Yan ZQ, Hansson GK. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 2007;219:187-203.
6. Schmid-Schonbein GW. Analysis of inflammation. Annu Rev Biomed Eng 2006;8: 93-131.
7. Nageh MF, Sandberg ET, Marotti KR, Lin AH, Melchior EP, Bullard DC et al. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1997;17:1517-1520.
8. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 2000;191: 189-194.
9. Bourdillon MC, Poston RN, Covacho C, Chignier E, Bricca G, McGregor JL. ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE(2/2)/ICAM-1(2/2)) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol 2000;20:2630-2635.
10. Kubo N, Boisvert WA, Ballantyne CM, Curtiss LK. Leukocyte CD11b expression is not essential for the development of atherosclerosis in mice. J Lipid Res 2000;41: 1060-1066.
11. Arai M, Lefer DJ, So T, DiPaula A, Aversano T, Becker LC. An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48 h reperfusion. J Am Coll Cardiol 1996;27:1278-1285.
12. Aversano T, Zhou W, Nedelman M, Nakada M, Weisman H. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion. J Am Coll Cardiol 1995;25:781-788.
13. Palazzo AJ, Jones SP, Girod WG, Anderson DC, Granger DN, Lefer DJ. Myocar-dial ischemia-reperfusion injury in CD18 and ICAM1-defcient mice. Am J Physiol 1998;275:H2300-H2307.
14. Simpson PJ, Todd RF III, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988;81:624-629.
15. Baran KW, Nguyen M, McKendall GR, Lambrew CT, Dykstra G, Palmeri ST et al. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation 2001;104:2778-2783.
16. Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol 2002;40:1199-1204.
17. Wilson RW, Ballantyne CM, Smith CW, Montgomery C, Bradley A, O'Brien WE et al. Gene targeting yields a CD18-mutant mouse for study of inflammation. J Immunol 1993;151:1571-1578.
18. Merched AJ, Williams E, Chan L. Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling. Arterioscler Thromb Vasc Biol 2003;23:1608-1614.
19. Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L et al. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 2003;107:2726-2732.
20. Merched AJ, Chan L. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis. Circulation 2004;110:3830-3841.
21. Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 2008;22:3595-3606.
22. Boullier A, Bird DA, Chang MK, Dennis EA, Friedman P, Gillotre-Taylor K et al. Scavenger receptors, oxidized LDL, and atherosclerosis. Ann NY Acad Sci 2001; 947:214-222.
23. Hamon Y, Chambenoit O, Chimini G. ABCA1 and the engulfment of apoptotic cells. Biochim Biophys Acta 2002;1585:64-71.
24. Imachi H, Murao K, Hiramine C, Sayo Y, Sato M, Hosokawa H et al. Human scavenger receptor B1 is involved in recognition of apoptotic thymocytes by thymic nurse cells. Lab Invest 2000;80:263-270.
25. Werman A, Werman-Venkert R, White R, Lee JK, Werman B, Krelin Y et al. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci USA 2004;101:2434-2439.
26. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y et al. Lack of interleukin-1 beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2003;23:656-660.
27. Hamon Y, Luciani MF, Becq F, Verrier B, Rubartelli A, Chimini G. Interleukin-1 beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood 1997;90:2911-2915.
28. Fadok VA, Chimini G. The phagocytosis of apoptotic cells. Semin Immunol 2001; 13:365-372.
29. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005;6:1182-1190.
30. Yonekawa K, Harlan JM. Targeting leukocyte integrins in human diseases. J Leukoc Biol 2005;77:129-140.